| Project/Area Number |
22590959
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Oita University (2012)
Kumamoto University (2010-2011) |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
WATANABE Masaki 熊本大学, 医学部附属病院, 助教 (40530150)
UCHINO Makoto 元熊本大学, 大学院・生命科学研究部, 教授 (20117336)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 神経機能学 / 血行再建療法 / 脳梗塞 / 急性期治療 / 脳血流SPECT / 血行再建 / 血管内治療 |
|---|
| Research Abstract |
Since 2011, endovascular therapies using thrombectomy devices are increasingly performed among patients with acute ischemic stroke in whom alteplase failed to recanalize or contraindicated. It is difficult to prove its efficacy by randomiz ed controlled therapy, however, as they require skilled endovascular speciallists. Thus, we developed a SPECT -based objective evaluating system by comparing predicted infarct volume on residual CBF and final infarct volume.
|
